BioImpedance CardioGraphy
Botox® in patients with idiopathic gastroparesis
Breast International Group 1-02
Breast International Group 1-06
Breast International Group 1-98
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast
Multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
Cost effectiveness of Aphasia Computer Treatment versus Usual Stimulation or attention control long term post stroke
Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis
Chemotherapy for patients with non-small cell lung cancer
Better Identification of Germs-Longitudinal Viral Epidemiology
Beaumont Interventional Group-Mevacor, ACE inhibitor, Colchicine restenosis trial
Brest International Group. A randomised, multi-centre, open-label, phase III study of adjuvant lapatinib, trastuzumab, their sequence and their combination in patients with HER2/ErbB2 positive primary breast cancer
Breast International Group. A randomised multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer
Improving Diagnosis and Management of Suspected Brain Infections Globally
BIGuanides and the Prevention of the Risk of Obesity study
Bipolar Disorder Genome Study
Busan Ulsan Gyeongnam Intestinal Study Group Society
Capecitabine compared with observation in resected biliary tract cancer
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects
Bleeding Independently associated with Mortality after noncardiac Surgery
Boosting Breastfeeding in Low-Income, Multi-ethnic Women: A Primary Care Based RCT
British Isles Network Of Congenital Anomaly Registers
The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis
BIOdegradable polymer and duRablE polymer drug-eluting Stents in an all COmeRs populaTion
Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease
Biomarkers and echocardiography in prediction of prognosis of chronic heart failure patients
Stockings to prevent the post-thrombotic syndrome biomarker substudy
Spanish Registry of biological therapies in rheumatic diseases
Spanish society of rheumatology database on biologic products
BIOpsychosocial approach of the CAncer-RElated FAtigue
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
BIOlogical Dose OPTimisation
Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions
Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)
BIOFLOW-III All-comers Orsiro Safety and Performance Registry
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
BIOLUX P-I First in Man Study
BIOTRONIK'S–First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries
BIOchemical Markers in Acute Coronary Syndromes
BIOchemical Markers in Acute Coronary Syndromes II
Biomarkers for Cardiovascular Risk Assessment in Europe
Biomarker Study to Identify the Acute Risk of a Coronary Syndrome
Biomonitoring and Cardiorenal Syndrome in Heart Failure Trial
BioNIR Ridaforolimus Eluting Coronary Stent System in Coronary Stenosis
A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
Spanish registry of patients with rheumatic disorders receiving biological drugs
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients
Behavioural Intervention for Opioid Reduction
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
Long-term outcomes of biological therapy in Crohn's disease complicated with internal fistulizing disease
First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold
Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold
BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry
A Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention